Randomized controlled trial testing the effectiveness of adaptive “SMART” stepped-care treatment for adults with binge-eating disorder comorbid with obesity
Datos Bibliográficos
| ID | 8712293 |
|---|---|
| Autores | Carlos M Grilo (0000-0003-0245-3444, autor de correspondencia), Marney A White (0000-0001-9856-6608), Robin M Masheb (0000-0002-6799-6012), Valentina Ivezaj (0000-0001-8760-8040), Peter Morgan (0000-0002-5973-5859), Peter T Morgan, Ralitza Gueorguieva (0000-0003-0944-5973) |
| Año | 2020 |
| Volumen | 75 |
| Número | 2 |
| Páginas | 204-218 |
| Fecha de publicación | 2020-02-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | American Psychologist (JOURNAL) |
| Identificadores de la revista | ISSN: 0003-066X • E-ISSN: 1935-990X |
| Editorial | American Psychological Association (PUBLISHER • US) |
| DOI | 10.1037/amp0000534 |
| PMID | 32052995 |
| OpenAlex | W3006384536 |
| Idioma | EN |
| Citas recibidas | 3 |
| Referencias citadas | 1 |
This randomized controlled trial (RCT) tested effectiveness of adaptive SMART stepped-care treatment to "standard" behavioral weight loss (BWL [standard]) for patients with binge-eating disorder (BED) and obesity. One hundred ninety-one patients were randomly assigned to 6 months of BWL (standard; n = 39) or stepped care (n = 152). Within stepped care, patients started with BWL for 1 month; treatment responders continued BWL, whereas nonresponders switched to cognitive-behavioral therapy (CBT), and patients receiving stepped care were additionally randomized to weight-loss medication or placebo (double-blind) for the remaining 5 months. Independent assessments were performed reliably at baseline, throughout treatment, and posttreatment. Intent-to-treat (ITT) analyses of remission rates (zero binges/month) revealed that BWL (standard) and stepped care did not differ (74.4% vs. 66.5%); within stepped care, remission rates ranged 40.0% to 83.3%, with medication significantly superior to placebo (overall) and among nonresponders switched to CBT. Mixed-models analyses of binge-eating frequency revealed significant time effects, but BWL (standard) and stepped care did not differ; within stepped care, medication was significantly superior to placebo and among nonresponders switched to CBT. Mixed models revealed significant weight loss, but BWL (standard; 5.1% weight-loss) and stepped care (5.8% weight-loss) did not differ; within stepped care (range = 0.4% to 8.8% weight-loss), medication was significantly superior to placebo and among both responders continued on BWL and nonresponders switched to CBT. In summary, BWL (standard) and adaptive stepped-care treatments produced robust improvements in binge eating and weight loss in patients with BED/obesity. Within adaptive stepped care, weight-loss medication enhanced outcomes for BED/obesity. Implications for clinical practice and future adaptive designs are offered. (PsycINFO Database Record (c) 2020 APA, all rights reserved)
Binge eating · Binge-eating disorder · Bulimia nervosa · Eating disorders · Obesity · Physical therapy · Psychiatry · Randomized controlled trial · Body Image and Dysmorphia Studies · Eating Disorders and Behaviors · Medicine · Pharmacology and Obesity Treatment · Psychology · Clinical Psychology · Internal Medicine
| Obras citantes distintas | 3 |
|---|---|
| Citas por año | 1 |
| Intervalo de citas | 2023 - 2025 (3) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 3 |